# Carter Bankshares, Inc.: financial statements, quarterly

CARE · Nasdaq · CIK 1829576 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/care.md) · [Financials](/companies/care/financials.md) · [Filings](/companies/care/filings.md) · [Insiders](/companies/care/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/care/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [21.5](/filings/0001829576-23-000053.md) | [24.4 d](/filings/0001829576-24-000016.md) | [25.6](/filings/0001829576-24-000036.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.8](/filings/0001829576-24-000070.md) | [(0.0) d](/filings/0001829576-26-000018.md) | [1.4](/filings/0001829576-25-000039.md) | [1.1](/filings/0001829576-25-000057.md) | [1.4](/filings/0001829576-25-000068.md) | [2.4 d](/filings/0001829576-26-000018.md) | [2.2](/filings/0001829576-26-000048.md) | [2.1](/filings/0001829576-26-000077.md) | [1.7](/filings/0001829576-25-000068.md) | [2.6 d](/filings/0001829576-26-000018.md) | [24.3](/filings/0001829576-26-000048.md) | [8.3](/filings/0001829576-26-000077.md) |
| Net income | $m | [3.6](/filings/0001829576-24-000070.md) | [(1.9) d](/filings/0001829576-26-000018.md) | [5.8](/filings/0001829576-25-000039.md) | [4.8](/filings/0001829576-25-000057.md) | [5.6](/filings/0001829576-25-000068.md) | [8.3 d](/filings/0001829576-26-000018.md) | [9.0](/filings/0001829576-26-000048.md) | [8.5](/filings/0001829576-26-000077.md) | [5.4](/filings/0001829576-25-000068.md) | [8.5 d](/filings/0001829576-26-000018.md) | [85.8](/filings/0001829576-26-000048.md) | [28.9](/filings/0001829576-26-000077.md) |
| Diluted EPS | $ per share | [0.16](/filings/0001829576-24-000070.md) | not reported | [0.25](/filings/0001829576-25-000039.md) | [0.21](/filings/0001829576-25-000057.md) | [0.24](/filings/0001829576-25-000068.md) | not reported | [0.39](/filings/0001829576-26-000048.md) | [0.37](/filings/0001829576-26-000077.md) | [0.24](/filings/0001829576-25-000068.md) | not reported | [3.88](/filings/0001829576-26-000048.md) | [1.31](/filings/0001829576-26-000077.md) |
| Basic EPS | $ per share | [0.16](/filings/0001829576-24-000070.md) | not reported | [0.25](/filings/0001829576-25-000039.md) | [0.21](/filings/0001829576-25-000057.md) | [0.24](/filings/0001829576-25-000068.md) | not reported | [0.39](/filings/0001829576-26-000048.md) | [0.37](/filings/0001829576-26-000077.md) | [0.24](/filings/0001829576-25-000068.md) | not reported | [3.88](/filings/0001829576-26-000048.md) | [1.31](/filings/0001829576-26-000077.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [105](/filings/0001829576-26-000077.md) | not reported | [277](/filings/0001829576-26-000077.md) |
| Total assets | $m | [4,452](/filings/0001829576-23-000053.md) | [4,513](/filings/0001829576-25-000016.md) | [4,555](/filings/0001829576-24-000036.md) | [4,533](/filings/0001829576-24-000056.md) | [4,613](/filings/0001829576-24-000070.md) | [4,659](/filings/0001829576-26-000018.md) | [4,700](/filings/0001829576-25-000039.md) | [4,784](/filings/0001829576-25-000057.md) | [4,840](/filings/0001829576-25-000068.md) | [4,852](/filings/0001829576-26-000077.md) | [4,799](/filings/0001829576-26-000048.md) | [4,802](/filings/0001829576-26-000077.md) |
| Total liabilities | $m | [4,122](/filings/0001829576-23-000053.md) | [4,161](/filings/0001829576-25-000016.md) | [4,196](/filings/0001829576-24-000036.md) | [4,168](/filings/0001829576-24-000056.md) | [4,227](/filings/0001829576-24-000070.md) | [4,275](/filings/0001829576-26-000018.md) | [4,299](/filings/0001829576-25-000039.md) | [4,378](/filings/0001829576-25-000057.md) | [4,427](/filings/0001829576-25-000068.md) | [4,432](/filings/0001829576-26-000077.md) | [4,294](/filings/0001829576-26-000048.md) | [4,263](/filings/0001829576-26-000077.md) |
| Shareholders' equity | $m | [331](/filings/0001829576-24-000070.md) | [351](/filings/0001829576-26-000018.md) | [359](/filings/0001829576-25-000057.md) | [364](/filings/0001829576-25-000068.md) | [387](/filings/0001829576-25-000068.md) | [384](/filings/0001829576-26-000077.md) | [402](/filings/0001829576-26-000077.md) | [406](/filings/0001829576-26-000077.md) | [413](/filings/0001829576-25-000068.md) | [420](/filings/0001829576-26-000077.md) | [505](/filings/0001829576-26-000077.md) | [539](/filings/0001829576-26-000077.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [9.3 d](/filings/0001829576-24-000070.md) | [7.9 d](/filings/0001829576-26-000018.md) | [17.6](/filings/0001829576-25-000039.md) | [(2.5) d](/filings/0001829576-25-000057.md) | [10.3 d](/filings/0001829576-25-000068.md) | [11.5 d](/filings/0001829576-26-000018.md) | [6.4](/filings/0001829576-26-000048.md) | [9.6 d](/filings/0001829576-26-000077.md) | [11.8 d](/filings/0001829576-25-000068.md) | [12.1 d](/filings/0001829576-26-000018.md) | [304](/filings/0001829576-26-000048.md) | [(261) d](/filings/0001829576-26-000077.md) |
| Capital expenditure | $m | [2.0 d](/filings/0001829576-24-000070.md) | [1.8 d](/filings/0001829576-26-000018.md) | [1.3](/filings/0001829576-25-000039.md) | [1.8 d](/filings/0001829576-25-000057.md) | [1.9 d](/filings/0001829576-25-000068.md) | [3.1 d](/filings/0001829576-26-000018.md) | [1.5](/filings/0001829576-26-000048.md) | [1.9 d](/filings/0001829576-26-000077.md) | [1.5 d](/filings/0001829576-25-000068.md) | [3.1 d](/filings/0001829576-26-000018.md) | [1.5](/filings/0001829576-26-000048.md) | [2.3 d](/filings/0001829576-26-000077.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [6.3 d](/filings/0001829576-24-000070.md) | [0.0 d](/filings/0001829576-26-000018.md) | [0.0](/filings/0001829576-24-000036.md) | [0.0 d](/filings/0001829576-25-000057.md) | [0.0 d](/filings/0001829576-25-000068.md) | [0.0 d](/filings/0001829576-26-000018.md) | not reported | not reported | [4.9 d](/filings/0001829576-25-000068.md) | [6.0 d](/filings/0001829576-26-000018.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [24.3](/filings/0001829576-23-000053.md) | [23.8](/filings/0001829576-24-000036.md) | [23.5](/filings/0001829576-24-000056.md) | [22.9](/filings/0001829576-24-000070.md) | [22.8](/filings/0001829576-25-000039.md) | [22.8](/filings/0001829576-25-000057.md) | [22.8](/filings/0001829576-25-000068.md) | [22.9](/filings/0001829576-26-000048.md) | [22.8](/filings/0001829576-26-000077.md) | [22.3](/filings/0001829576-25-000068.md) | [21.8](/filings/0001829576-26-000048.md) | [21.8](/filings/0001829576-26-000077.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 22,163,931 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001829576-26-000077.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.